Baird Maintains Bullish View on Intercept Pharmaceuticals (ICPT), Concerns Overblown

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. WYFI
6. STUB
7. EAT
8. BTGO
9. NVDA
10. GO

Go back to Baird Maintains Bullish View on Intercept Pharmaceuticals (ICPT), Concerns Overblown

Intercept Pharma (ICPT) Tops Q3 EPS by 23c

November 3, 2016 7:09 AM EDT

Intercept Pharma (NASDAQ: ICPT) reported Q3 EPS of ($3.59), versus the analyst estimate of ($3.82). Revenue for the quarter came in at $4.7 million versus the consensus estimate of $4.77 million.

For the three months ended September 30, 2016, Intercept reported a net loss of $88.8 million. GAAP operating expense for the... More